Methotrexate Suppresses Psoriatic Skin Inflammation by Inhibiting Muropeptide Transporter SLC46A2 Activity

Investigators focused on Slc46a2, which was highly expressed in mammalian epidermal keratinocytes, and showed that it was critical for the delivery of diaminopimelic acid-muropeptides and activation of NOD1 in keratinocytes.